Our Brief History
We have been committed to diversity and innovation from the start.
and focuses on researching and providing medicines, speciality pharmaceuticals and consumer healthcare products.
where our family company acquired our first community pharmacy.. Over time we had reached fourteen community pharmacies which were later divested.
was incorporated and became part of the Typharm Group, March 1993.
was acquired by the family group.
was established by the group, providing a second manufacturing company in September 2008.
retail pharmacy chain was established.
were launched in November 2011, Amdeepcha’s first specialty generic product.
launched, with an award winning, best-in-class marketing campaign
was introduced in October 2017, as the UK’s first generic Carbocisteine Syrup
this time in the anti-inflammatory therapy area, with Diclofenac Sodium
specialty generic implant, for the treatment of prostate cancer; subsequently divested.
purpose built office and production facilities with MHRA approval.
extending full like assembly for US, UK and EU customers
successfully launched as a competitive, branded anti-inflammatory pain relief gel.
(for adults) launched successfully into the UK Market
